Crossmark

Stability indicating RP-UPLC determination of three antiviral agents: emtricitabine, tenofovir, and rilpivirine in combined pharmaceutical dosage form

Crossref DOI link: https://doi.org/10.1186/s43094-025-00765-y

Published Online: 2025-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kommineni, Vinutha https://orcid.org/0000-0003-4582-4508
Pohar, Spoorthi

Lakshmi, N. Sri

Latha, N. Swarna
License Information

Text and Data Mining valid from 2025-02-17

Version of Record valid from 2025-02-17
More Information

Article History

Received: 11 November 2024

Accepted: 4 January 2025

First Online: 17 February 2025

Declarations

:

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below